UCB's Global Corporate Website

New data show UCB’s commitment to rheumatology

Posted by
Andrea Levin, Public Relations & Communications, UCB Inc.
We were in Washington, D.C. from November, 9 to 14, highlighting new research data in several areas of interest to rheumatology experts.

The American College of Rheumatology (ACR) 2012 Annual Scientific Meeting is a great place to share and discuss current and emerging therapies for conditions including rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic lupus erythematosus (SLE).

Our exhibition booth was a hive of activity all week. We were also  proud to sponsor four oral presentations and 16 posters. These included presentations of long-term data on our rheumatoid arthritis medicine and insights into therapies which are still under development.

Our commitment to rheumatology is in keeping with our ongoing efforts to provide treatments to people with severe chronic conditions. The range of research data shared in Washington demonstrates this continued investment in helping to address the needs of people living with a broad range of rheumatic diseases.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.

3 + 3 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.